Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
12.73
-0.63 (-4.72%)
Jan 28, 2026, 4:00 PM EST - Market closed
Wave Life Sciences Market Cap
Wave Life Sciences has a market cap or net worth of $2.33 billion as of January 29, 2026. Its market cap has increased by 32.35% in one year.
Market Cap
2.33B
Enterprise Value
2.15B
1-Year Change
32.35%
Ranking
Category
Stock Price
$12.73
Market Cap Chart
Since November 11, 2015, Wave Life Sciences's market cap has increased from $334.93M to $2.33B, an increase of 595.53%. That is a compound annual growth rate of 20.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 2.44B | -21.41% |
| Dec 31, 2025 | 3.11B | 64.89% |
| Dec 31, 2024 | 1.89B | 213.58% |
| Dec 29, 2023 | 601.65M | -1.10% |
| Dec 30, 2022 | 608.37M | 229.32% |
| Dec 31, 2021 | 184.73M | -51.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Travere Therapeutics | 2.63B |
| Mineralys Therapeutics | 2.59B |
| Telix Pharmaceuticals | 2.55B |
| Spyre Therapeutics | 2.49B |
| Recursion Pharmaceuticals | 2.46B |
| Mesoblast | 2.38B |
| Ultragenyx Pharmaceutical | 2.33B |
| Ascentage Pharma Group International | 2.32B |